Table 2.
Co-morbidities. Comparison between patients dead and/or admitted to ICU with OTI and patients alive and/or not admitted to ICU.
| Alive and/or not admitted to ICU 219 pts | Dead and/or admitted to ICU with OTI 68 pts | p | |
|---|---|---|---|
| Demographics | |||
| Mean age ± SD | 61.9 ± 12.2 | 71.3 ± 11.2 | < 0.0001 |
| Females | 62 (28.3%) | 24 (35.2%) | 0.2907 |
| Males | 157 (71.7%) | 44 (64.8%) | 0.2907 |
| Co-morbidities | |||
| Blood hypertension | 90 (41.0%) | 46 (67.6%) | 0.0002 |
| Cardiovascular diseases | 36 (16.4%) | 17 (25%) | 0.1511 |
| Diabetes | 33 (15.0%) | 13 (19.1%) | 0.4508 |
| Chronic pneumopathies | 15 (6.8%) | 9 (13.2%) | 0.1294 |
| Renal failure (creatinine clearance < 50 ml/min) | 7 (3.2%) | 9 (13.2%) | 0.0040 |
| Chronic inflammatory diseases | 2 (0.9%) | 2 (2.9%) | 0.2390 |
| Dementia | 5 (2.3%) | 4 (5.8%) | 0.2231 |
| Cancer | 3 (1.3%) | 2 (2.9%) | 0.3394 |
| Smoke | 27 (12.3%) | 11 (16.1%) | 0.4167 |
| At least one of the abovementioned co-morbidities | 126 (57.5%) | 54 (79.4%) | 0.0010 |
| Home-treatment | |||
| ACE inhibitors/sartans | 55 (25.1%) | 24 (35.2%) | 0.1201 |
| DOAC/VKA | 10 (4.5%) | 7 (10.2%) | 0.1358 |
| Antiplatelet agents | 30 (13.6%) | 17 (25%) | 0.0381 |
Legend: DOAC=direct oral anticoagulant; VKA=vitamin K antagonist; ICU=Intensive Care Unit; OTI=oro-tracheal intubation; SD=standard deviation.